Trial Profile
Effect of Rosuvastatin on Function of High Density Lipoprotein Cholesterol in Patients With Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Therapeutic Use
- 22 Sep 2017 Primary endpoint has been met. (Functional HDL-C) as per results published in the Circulation Journal
- 22 Sep 2017 Results published in the Circulation Journal
- 02 May 2016 Status changed from recruiting to completed.